CoChat

Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients

Open access
Oliveto, Alison, Poling, James, Mancino, Michael J., Feldman, Zachary, Cubells, Joseph F., Pruzinsky, Rhonda, Gonsai, Kishorchandra, Cargile, Christopher, Sofuoglu, Mehmet, Chopra, Mohit P., Gonzalez-Haddad, Gerardo, Carroll, Kathleen M., Kosten, Thomas R. · 2011 · Drug and Alcohol Dependence
Cited by 70

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

This study examined the dose-related efficacy of disulfiram for treating cocaine dependence in methadone-stabilized cocaine dependent participants. Design One hundred sixty-one cocaine-and opioid-dependent volunteers were entered into a 14-week, double blind, randomized, placebo-controlled clinical trial at two sites. Methods Participants were stabilized on methadone during weeks 1–2 and received disulfiram at 0, 62.5, 125 or 250 mg/day during weeks 3–14. All participants also received weekly cognitive behavioral therapy. Thrice-weekly urine samples and weekly self-reported drug use assessments were obtained. Results Baseline subject characteristics, retention and drug use did not differ across groups. Outcome analyses were performed on those who participated beyond week 2. Opioid positive urine samples and self-reported opioid use did not differ by treatment group. The prevalence of alcohol use was low prior to and during the trial and did not differ by treatment group. Cocaine-positive urines increased over time in the 62.5 and 125 mg disulfiram groups and decreased over time in the 250 mg disulfiram and placebo groups (p<0.0001). Self-reported cocaine use increased in the 125 mg disulfiram group relative to the other three treatment groups (p=0.04). Conclusions Disulfiram may be contraindicated for cocaine dependence at doses less than 250 mg/day. Whether disulfiram at higher doses is efficacious in reducing cocaine use in dually cocaine and opioid dependent individuals needs to be determined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2010.07.022

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 55

  1. Baker, 2007, Disulfiram effects on responses to intravenous cocaine administration, Drug Alcohol Depend., 87, 202, 10.1016/j.drugalcdep.2006.08.016 · DOI
  2. Black, 1987, The effect of increased cocaine use on drug treatment, Addict. Behav., 12, 289, 10.1016/0306-4603(87)90042-6 · DOI
  3. Bovasso, 2003, The long-term outcomes of drug use by methadone maintenance patients, J. Behav. Health Serv. Res., 30, 290, 10.1007/BF02287318 · DOI
  4. Bryk, 1987, Application if hierarchical linear models to assessing change, Psychol. Bull., 101, 147, 10.1037/0033-2909.101.1.147 · doi:10.1037/0033-2909.101.1.147 · Paper page
  5. Bux, 1995, Cocaine use and HIV risk behavior in methadone maintenance patients, Drug Alcohol Depend., 37, 29, 10.1016/0376-8716(94)01058-S · DOI
  6. Carboni, 1990, Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals, J. Neurochem., 55, 1067, 10.1111/j.1471-4159.1990.tb04599.x · DOI · Paper page
  7. Carroll, 2004, Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial, Arch. Gen. Psychiatry, 61, 264, 10.1001/archpsyc.61.3.264 · DOI · Paper page
  8. Carroll, 1998, Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram, Addiction, 93, 713, 10.1046/j.1360-0443.1998.9357137.x · DOI · Paper page
  9. Carroll, 1993, Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance, J. Stud. Alcohol, 54, 199, 10.15288/jsa.1993.54.199 · DOI · Paper page
  10. Compton, 1995, Results of the NIDA treatment demonstration grants’ cocaine workgroup: characteristics of cocaine users and HIV risk behaviors, Drug Alcohol Depend., 37, 1, 10.1016/0376-8716(94)01061-O · DOI
  11. Condelli, 1991, Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions, J. Subst. Abuse Treat., 8, 203, 10.1016/0740-5472(91)90040-H · DOI
  12. Cubells, 2004, DBH genotype in disulfiram treatment for cocaine dependence, Neuropsychopharmacology, 29, S72
  13. Cubells, 2004, Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology, Psychopharmacology (Berl.), 174, 463, 10.1007/s00213-004-1840-8 · DOI · Paper page
  14. de Lima, 2002, Pharmacological treatment of cocaine dependence: a systematic review, Addiction, 97, 931, 10.1046/j.1360-0443.2002.00209.x · DOI · Paper page
  15. Disney, 2005, Prevalence and correlates of cocaine physical dependence subtypes using the DSM-IV in outpatients receiving opioid agonist medication, Drug Alcohol Depend., 79, 23, 10.1016/j.drugalcdep.2004.11.012 · DOI
  16. Dobler-Mikola, 2005, Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment, J. Subst. Abuse Treat., 29, 259, 10.1016/j.jsat.2005.08.002 · DOI
  17. El-Bassel, 2004, Physical and sexual intimate partner violence among women in methadone maintenance treatment, Psychol. Addict. Behav., 18, 180, 10.1037/0893-164X.18.2.180 · DOI · Paper page
  18. Gawin, 1986, Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: Clinical observations, Arch. Gen. Psychiatry, 43, 107, 10.1001/archpsyc.1986.01800020013003 · DOI · Paper page
  19. George, 2000, Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial, Biol. Psychiatry, 47, 1080, 10.1016/S0006-3223(99)00310-8 · DOI · Paper page
  20. Gibbons, 1993, Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset, Arch. Gen. Psychiatry, 50, 739, 10.1001/archpsyc.1993.01820210073009 · DOI · Paper page
  21. Grella, 1995, Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients, Drug Alcohol Depend., 37, 15, 10.1016/0376-8716(94)01059-T · DOI
  22. Haley, 1979, Disulfiram (tetraethylthioperoxydicarbonic diamide): a reappraisal of its toxicity and therapeutic application, Drug Metab. Rev., 9, 319, 10.3109/03602537908993897 · DOI
  23. Hameedi, 1995, Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans, Biol. Psychiatry, 37, 560, 10.1016/0006-3223(94)00361-6 · DOI
  24. Hartell, 1995, Heroin use during methadone maintenance treatment: the importance of methadone doe and cocaine use, Am. J. Publ. Health, 85, 83, 10.2105/AJPH.85.1.83 · DOI · Paper page
  25. Higgins, 1996, Alcohol pretreatment increases preference for cocaine over monetary reinforcement, Psychopharmacology, 123, 1, 10.1007/BF02246274 · DOI
  26. Honjo, 1969, Inhibition of drug demethylation by disulfiram in vivo and in vitro, Biochem. Pharmacol., 18, 2681, 10.1016/0006-2952(69)90201-9 · DOI
  27. Hunt, 1986, The costly bonus: cocaine related crime among methadone treatment clients, Adv. Alcohol Subst. Abuse, 6, 107, 10.1300/J251v06n02_08 · DOI
  28. Jatlow, 1991, Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion, Life Sci., 48, 1787, 10.1016/0024-3205(91)90217-Y · DOI · Paper page
  29. Karamanakos, 2001, Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism, Pharmacol. Toxicol., 88, 106, 10.1034/j.1600-0773.2001.088002106.x · DOI · Paper page
  30. King, 2001, Influence of antisocial personality subtypes on drug abuse treatment response, J. Nerv. Ment. Dis., 189, 593, 10.1097/00005053-200109000-00004 · DOI
  31. Kosten, 2003, Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained paintents, Drug Alcohol Depend., 70, 315, 10.1016/S0376-8716(03)00032-2 · DOI
  32. Kosten, 1988, Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up, J. Nerv. Ment. Dis., 176, 176, 10.1097/00005053-198803000-00006 · DOI · Paper page
  33. Ledgerwood, 2002, Relationship between problem gambling and substance use in a methadone maintenance population, Addict. Behav., 27, 483, 10.1016/S0306-4603(01)00187-3 · DOI
  34. Lima, 2002, Carbamazepine for cocaine dependence, Cochrane Database Syst. Rev., 10.1002/14651858.CD003727.pub2 · DOI
  35. Lima, 2003, Antidepressants for cocaine dependence, Cochrane Database Syst. Rev., 10.1002/14651858.CD002950 · DOI · Paper page
  36. MacGowan, 1997, Factors associated with client-reported HIV infection among clients entering methadone treatment, AIDS Educ. Prev., 9, 205
  37. Magura, 1998, Pre- and in-treatment predictors of retention in methadone treatment using survival analysis, Addiction, 93, 51, 10.1046/j.1360-0443.1998.931516.x · DOI · Paper page
  38. Magura, 2002, Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial, Subst. Use Misuse, 37, 1927, 10.1081/JA-120016225 · DOI · Paper page
  39. McCance-Katz, 1998, Chronic disulfiram treatment effects on intranasal cocaine administration: initial results, Biol. Psychiatry, 43, 540, 10.1016/S0006-3223(97)00506-4 · DOI · Paper page
  40. McCance-Katz, 1998, Disulfiram effects on acute cocaine administration, Drug Alcohol Depend., 52, 27, 10.1016/S0376-8716(98)00050-7 · DOI · Paper page
  41. McCance-Katz, 1993, Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene, Psychopharmacology (Berl.), 111, 39, 10.1007/BF02257405 · DOI · Paper page
  42. McCance, 1995, Cocaethylene: pharmacology, physiology and behavioral effects in humans, J. Pharmacol. Exp. Ther., 274, 215, 10.1016/S0022-3565(25)10557-0 · DOI · Paper page
  43. McLellan, 1980, An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index, J. Nerv. Ment. Dis., 168, 26, 10.1097/00005053-198001000-00006 · DOI · Paper page
  44. Meandzija, 1994, HIV infection and cocaine use in methadone maintained and untreated intravenous drug users, Drug Alcohol Depend., 36, 109, 10.1016/0376-8716(94)90092-2 · DOI
  45. Mulvaney, 1999, Cocaine abstinence symptomatology and treatment attrition, J. Subst. Abuse Treat., 16, 129, 10.1016/S0740-5472(98)00017-8 · DOI · Paper page
  46. Oliveto, 2005, Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients, Drug Alcohol Depend., 79, 157, 10.1016/j.drugalcdep.2005.01.007 · DOI
  47. Pani, 2010, Disulfiram for the treatment of cocaine dependence, Cochrane Database Syst. Rev., 10.1002/14651858.CD007024.pub2 · DOI · Paper page
  48. Petrakis, 2000, Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts, Addiction, 95, 219, 10.1046/j.1360-0443.2000.9522198.x · DOI · Paper page
  49. Soares, 2004, Dopamine agonists for cocaine dependence, Cochrane Database Syst. Rev.
  50. Stanley, 1997, Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase, Br. J. Pharmacol., 121, 1803, 10.1038/sj.bjp.0701315 · DOI · Paper page
  51. Stewart, 1979, Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases, Clin. Pharmacol. Ther., 25, 464, 10.1002/cpt1979254464 · DOI · Paper page
  52. Tanda, 1997, Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine, Eur. J. Neurosci., 9, 2077, 10.1111/j.1460-9568.1997.tb01375.x · DOI · Paper page
  53. Williamson, 2006, The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence, Drug Alcohol Depend., 81, 293, 10.1016/j.drugalcdep.2005.08.010 · DOI
  54. Wolf, 2004, Methadone-related deaths in Palm Beach County, J. Forensic Sci., 49, 375, 10.1520/JFS2003221 · DOI
  55. Wright, 1990, Disulfiram treatment of alcoholism, Am. J. Med., 88, 647, 10.1016/0002-9343(90)90534-K · DOI · Paper page

Cited by

See all 70

Metadata

Authors
Oliveto, A., Poling, J., Mancino, M. J., Feldman, Z., Cubells, J. F., Pruzinsky, R., Gonsai, K., Cargile, C., Sofuoglu, M., Chopra, M. P., Gonzalez-Haddad, G., Carroll, K. M., & Kosten, T. R.
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2011-01
Volume
113
Issue
2-3
Pages
184-191
ISSN
0376-8716 (ISSN-L)
OpenAlex
W1990473903
Cited by
70
References
5
FWCI
5.24
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2010.07.022
The paper
Oliveto, A., Poling, J., Mancino, M. J., Feldman, Z., Cubells, J. F., Pruzinsky, R., Gonsai, K., Cargile, C., Sofuoglu, M., Chopra, M. P., Gonzalez-Haddad, G., Carroll, K. M., & Kosten, T. R. (2011). Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2010.07.022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.